Zobrazeno 1 - 10
of 1 109
pro vyhledávání: '"NK Cell Lectin-Like Receptor Subfamily D"'
Autor:
Li J; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China., Wang X; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China. Electronic address: wangxianwei@ustc.edu.cn., Cao G; Hefei TG ImmunoPharma Corporation Limited, Hefei, China., Wu Y; Hefei TG ImmunoPharma Corporation Limited, Hefei, China., Cheng M; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China., Chen Y; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China., Sun H; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Sun R; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China., Peng H; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China. Electronic address: huipeng@ustc.edu.cn., Tian Z; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China; Hefei TG ImmunoPharma Corporation Limited, Hefei, China. Electronic address: tzg@ustc.edu.cn.
Publikováno v:
Cancer letters [Cancer Lett] 2024 Nov 28; Vol. 605, pp. 217305. Date of Electronic Publication: 2024 Oct 17.
Autor:
Shimojima Y; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. yshimoji@shinshu-u.ac.jp., Ichikawa T; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan., Kishida D; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan., Takamatsu R; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan., Sekijima Y; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Publikováno v:
Immunologic research [Immunol Res] 2024 Oct; Vol. 72 (5), pp. 1108-1119. Date of Electronic Publication: 2024 Jul 03.
Autor:
Tsao T; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; T. Tsao and L. Qiu contributed equally., Qiu L; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; T. Tsao and L. Qiu contributed equally., Bharti R; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Shemesh A; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy San Francisco, San Francisco, CA, USA., Hernandez AM; Parker Institute for Cancer Immunotherapy San Francisco, San Francisco, CA, USA.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Cleary SJ; Institute of Pharmaceutical Science, King's College London, London, UK., Greenland NY; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Santos J; Department of Surgery, University of California San Francisco - East Bay, Oakland, CA, USA., Shi R; Dren Bio, Foster City, CA, USA., Bai L; Dren Bio, Foster City, CA, USA., Richardson J; Dren Bio, Foster City, CA, USA., Dilley K; Dren Bio, Foster City, CA, USA., Will M; Dren Bio, Foster City, CA, USA., Tomasevic N; Dren Bio, Foster City, CA, USA., Sputova T; Dren Bio, Foster City, CA, USA., Salles A; Dren Bio, Foster City, CA, USA., Kang J; Dren Bio, Foster City, CA, USA., Zhang D; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Hays SR; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Kukreja J; Department of Surgery, University of California San Francisco, San Francisco, CA, USA., Singer JP; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Lanier LL; Parker Institute for Cancer Immunotherapy San Francisco, San Francisco, CA, USA.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Looney MR; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Greenland JR; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Medical Service, Veterans Affairs Health Care System, San Francisco, CA, USA., Calabrese DR; Department of Medicine, University of California San Francisco, San Francisco, CA, USA daniel.calabrese@ucsf.edu.; Medical Service, Veterans Affairs Health Care System, San Francisco, CA, USA.
Publikováno v:
The European respiratory journal [Eur Respir J] 2024 Sep 26; Vol. 64 (3). Date of Electronic Publication: 2024 Sep 26 (Print Publication: 2024).
Autor:
Ngiow SF; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Manne S; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Huang YJ; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Azar T; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Chen Z; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Mathew D; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chen Q; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Khan O; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wu JE; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Alcalde V; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA., Flowers AJ; Tara Miller Melanoma Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., McClain S; Tara Miller Melanoma Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Baxter AE; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kurachi M; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Shi J; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Huang AC; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Giles JR; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Sharpe AH; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA; Gene Lay Institute of Immunology and Inflammation at Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Vignali DAA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Wherry EJ; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: wherry@pennmedicine.upenn.edu.
Publikováno v:
Cell [Cell] 2024 Aug 08; Vol. 187 (16), pp. 4336-4354.e19.
Autor:
Selim MA; Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt., Suef RA; Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt., Saied E; Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt., Abdel-Maksoud MA; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia., Almutairi SM; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia., Aufy M; Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, Vienna, Austria., Mousa AA; Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt., Mansour MTM; Virology and Immunology Department, National Cancer Institute, Cairo University and Childern's Cancer Hospital, Cairo, Egypt., Farag MMS; Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.; Biomedical Research Department, Armed Forces College of Medicine (AFCM), Cairo, Egypt.; The Regional Centre for Mycology and Biotechnology, Al-Azhar University, Cairo, Egypt.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Sep 12; Vol. 15, pp. 1427519. Date of Electronic Publication: 2024 Sep 12 (Print Publication: 2024).
Autor:
MacLachlan BJ; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia., Sullivan LC; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Australia., Brooks AG; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Australia., Rossjohn J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.; Institute of Infection and Immunity, School of Medicine, Cardiff University, UK., Vivian JP; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Publikováno v:
The FEBS journal [FEBS J] 2024 Apr; Vol. 291 (7), pp. 1530-1544. Date of Electronic Publication: 2024 Jan 10.
Autor:
Marin IA; Department of Biology, Stanford University, Stanford, CA 94035.; Department of Neurobiology, Stanford University, Stanford, CA 94035., Gutman-Wei AY; Department of Biology, Stanford University, Stanford, CA 94035.; Department of Neurobiology, Stanford University, Stanford, CA 94035., Chew KS; Department of Biology, Stanford University, Stanford, CA 94035.; Department of Neurobiology, Stanford University, Stanford, CA 94035., Raissi AJ; Department of Biology, Stanford University, Stanford, CA 94035.; Department of Neurobiology, Stanford University, Stanford, CA 94035., Djurisic M; Department of Biology, Stanford University, Stanford, CA 94035.; Department of Neurobiology, Stanford University, Stanford, CA 94035., Shatz CJ; Department of Biology, Stanford University, Stanford, CA 94035.; Department of Neurobiology, Stanford University, Stanford, CA 94035.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jun 07; Vol. 119 (23), pp. e2203965119. Date of Electronic Publication: 2022 Jun 01.
Autor:
Huang RY; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey United States., Wang Y; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey United States., Jhatakia AD; Discovery Biology, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Deng AX; Discovery Biotherapeutics, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Bee C; Discovery Biotherapeutics, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Deshpande S; Discovery Biotherapeutics, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Rangan VS; Discovery Biotherapeutics, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Bezman N; Discovery Biology, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Gudmundsson O; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey United States., Chen G; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey United States.
Publikováno v:
Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2021 Jul 07; Vol. 32 (7), pp. 1567-1574. Date of Electronic Publication: 2021 Jan 08.
Autor:
Dupont MSJ; Innate Immunity Unit, Immunology Department, Institut Pasteur, 75724 Paris, France.; INSERM U1223, 75724 Paris, France.; Université de Paris, Sorbonne Paris Cité, 75013 Paris, France., Guillemot V; Bioinformatics and Biostatistics Hub, Computational Biology Department, Institut Pasteur, 75724 Paris, France., Campagne P; Bioinformatics and Biostatistics Hub, Computational Biology Department, Institut Pasteur, 75724 Paris, France., Serafini N; Innate Immunity Unit, Immunology Department, Institut Pasteur, 75724 Paris, France.; INSERM U1223, 75724 Paris, France., Marie S; Innate Immunity Unit, Immunology Department, Institut Pasteur, 75724 Paris, France.; INSERM U1223, 75724 Paris, France., Montagutelli X; Mouse Genetics Laboratory, Department of Genomes and Genetics, Institut Pasteur, 75724 Paris, France., Di Santo JP; Innate Immunity Unit, Immunology Department, Institut Pasteur, 75724 Paris, France.; INSERM U1223, 75724 Paris, France., Vosshenrich CAJ; Innate Immunity Unit, Immunology Department, Institut Pasteur, 75724 Paris, France; christian.vosshenrich@pasteur.fr.; INSERM U1223, 75724 Paris, France.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Mar 09; Vol. 118 (10).
Autor:
Prašnikar E; National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.; Graduate School of Biomedicine, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia., Perdih A; National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.; Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia., Borišek J; National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.
Publikováno v:
Journal of chemical information and modeling [J Chem Inf Model] 2021 Jul 26; Vol. 61 (7), pp. 3593-3603. Date of Electronic Publication: 2021 Jul 01.